Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| TiGenix NV, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| TiGenix NV, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| TiGenix NV, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| TiGenix NV, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| TiGenix NV, Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| TiGenix NV, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
| TiGenix NV, Pharmaceuticals &Healthcare, Deal Details | 11 | 26 |
| Partnerships | 11 | 1 |
| TiGenix Forms Partnership with TFS International | 11 | 1 |
| TiGenix To Enter Into Co-Marketing Agreement For Cx601 | 12 | 1 |
| TiGenix Enters Into Joint Venture With Katholieke Universiteit Leuven, Ghent University And Therosteon | 13 | 2 |
| Merger | 15 | 1 |
| TiGenix Completes Merger With Cellerix | 15 | 2 |
| Licensing Agreements | 17 | 1 |
| Takeda Pharma Enters into Licensing Agreement with TiGenix for Cx601 | 17 | 2 |
| TiGenix Enters Licensing Agreement With Sobi For ChondroCelect | 19 | 2 |
| Equity Offering | 21 | 1 |
| TiGenix Raises USD26 Million in Private Placement of Shares | 21 | 2 |
| TiGenix Files Registration Statement for IPO of ADS for up to USD57.5 Million | 23 | 2 |
| TiGenix Raises USD9.2 Million in Private Placement of Shares | 25 | 2 |
| TiGenix Completes Private Placement Of Shares For US$16.2 Million | 27 | 2 |
| TiGenix Completes Private Placement Of Shares For US$8.5 Million | 29 | 1 |
| TiGenix Completes Private Placement Of Shares For US$9 Million | 30 | 1 |
| Debt Offering | 31 | 1 |
| TiGenix Raises USD28.3 Million in Private Placement of 9% Bonds Due 2018 | 31 | 2 |
| TiGenix Announces Private Placement Of Debt Securities For US$13.7 Million | 33 | 1 |
| Acquisition | 34 | 1 |
| TiGenix Acquires Coretherapix from Genetrix | 34 | 2 |
| PharmaCell Completes Acquisition of TiGenix, Operator of Cell Therapy Production Facility in Netherlands for USD7.8 Million | 36 | 1 |
| TiGenix NV - Key Competitors | 37 | 1 |
| Key Employees | 38 | 1 |
| Locations And Subsidiaries | 39 | 1 |
| Head Office | 39 | 1 |
| Other Locations &Subsidiaries | 39 | 1 |
| Appendix | 40 | 1 |
| Methodology | 40 | 1 |
| About GlobalData | 40 | 1 |
| Contact Us | 40 | 1 |
| Disclaimer | 40 | 1 |